Ambu gets recommendation from FDA, analyst doubts effect

The FDA recommendation that single-use bronchoscopes are used at US hospitals will have little effect, as US lung specialists gave the same advice over a year ago, says Niels Granholm-Leth, Head of Equity Research at Carnegie.
Photo: Ambu / PR
Photo: Ambu / PR
by ulrich quistgaard, translated by catherine brett

On Friday, the US Food and Drug Administration (FDA) recommended that doctors at US hospitals use single-use bronchoscopes instead of reusable scopes – one year after the American Lung Association gave the same advice.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading